Profile data is unavailable for this security.
About the company
Hunan Warrant Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of chemical raw materials, chemical pharmaceutical preparations and traditional Chinese medicine preparations. The Company's products include pharmaceutical preparations, raw materials and intermediates, plant extracts and food. Its products cover areas such as digestion, breathing, and anti-infection. The Company mainly conducts business within the domestic market.
- Revenue in CNY (TTM)1.45bn
- Net income in CNY211.45m
- Incorporated2001
- Employees1.16k
- LocationHunan Warrant Pharmaceutical Co LtdBuilding C6-C7, Jinrui Lugu ScienceTechnology Park, No. 28 Lutian RoadCHANGSHA 410006ChinaCHN
- Phone+86 73 185910599
- Fax+86 73 185910568
- Websitehttp://www.warrant.com.cn
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Shapuaisi Pharmaceutical Co Ltd | 505.58m | -84.79m | 3.50bn | 1.39k | -- | 2.08 | -- | 6.93 | -0.2245 | -0.2245 | 1.34 | 4.44 | 0.2408 | 2.86 | 13.81 | 365,039.00 | -3.93 | -0.7573 | -4.52 | -0.8713 | 50.29 | 58.02 | -16.32 | -2.45 | 1.04 | -- | 0.1236 | -- | 17.37 | 1.21 | -43.23 | -- | 30.36 | -- |
| Obio Technology Shanghai Corp Ltd | 251.68m | -246.61m | 3.63bn | 731.00 | -- | 1.94 | -- | 14.41 | -0.3834 | -0.3834 | 0.3915 | 2.89 | 0.1012 | 4.00 | 2.55 | 344,293.00 | -9.93 | 0.2246 | -11.17 | 0.2514 | -26.42 | 36.72 | -98.16 | 1.48 | 2.27 | -- | 0.104 | 0.00 | -29.69 | 35.88 | -425.90 | -- | 57.00 | -- |
| Hunan Warrant Pharmaceutical Co Ltd | 1.45bn | 211.45m | 3.70bn | 1.16k | 17.49 | 1.96 | -- | 2.56 | 2.25 | 2.25 | 15.42 | 20.06 | 0.6426 | 1.49 | 9.74 | 1,244,707.00 | 8.34 | 11.21 | 9.79 | 14.05 | 61.32 | 69.00 | 12.98 | 13.96 | 3.18 | -- | 0.0566 | 8.05 | 10.84 | 18.50 | 15.60 | 19.02 | 24.49 | -- |
| Beijing Konruns Pharmaceutical Co Ltd | 846.29m | 114.79m | 3.80bn | 447.00 | 32.48 | 1.19 | -- | 4.49 | 0.7311 | 0.7311 | 5.38 | 20.03 | 0.2178 | 1.95 | 2.90 | 1,893,258.00 | 3.81 | 5.43 | 4.48 | 6.24 | 87.83 | 89.93 | 17.52 | 20.76 | 3.36 | -- | 0.0582 | 21.53 | 6.15 | -2.08 | 48.24 | -10.63 | 43.05 | -9.71 |
| Jiangsu Aidea Pharmaceutical Co Ltd | 408.68m | -104.55m | 3.88bn | 476.00 | -- | 3.62 | -- | 9.48 | -0.2384 | -0.2384 | 0.9459 | 2.54 | 0.2193 | 0.9553 | 2.66 | 858,576.30 | -5.65 | -2.40 | -8.32 | -2.85 | 48.96 | 39.00 | -25.77 | -10.15 | 1.11 | -- | 0.3018 | -- | 68.44 | 8.24 | 38.75 | -- | -4.47 | -- |
Data as of Nov 05 2024. Currency figures normalised to Hunan Warrant Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
15.97%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 1.31m | 6.56% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 514.89k | 2.58% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 445.35k | 2.23% |
| Essence Fund Co., Ltd.as of 30 Jun 2024 | 325.59k | 1.63% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 238.11k | 1.19% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 199.79k | 1.00% |
| Great Wall Fund Management Co., Ltd.as of 30 Jun 2024 | 96.86k | 0.49% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2024 | 22.52k | 0.11% |
| China Nature Asset Management Co., Ltd.as of 30 Jun 2024 | 22.00k | 0.11% |
| Hui'an Fund Management Co. Ltd.as of 30 Jun 2024 | 13.99k | 0.07% |
More ▼
Data from 30 Jun 2024 - 29 Oct 2024Source: FactSet Research Systems Inc.
